This is a guest post from Guillaume Desachy, Statistical Science Director at AstraZeneca. Since March 2022, Guillaume has been leading a team of 15 collaborators focusing on building the community of R users at AstraZeneca, called R @ AZ.
Get in touch on LinkedIn.
Back in early 2021, a few of us at AstraZeneca got together and reflected on the growing importance of R in our organization. R was far from being a new thing at AstraZeneca and a long way from being a fad.
However, …